BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16322267)

  • 1. Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation.
    Nair HB; Luthra R; Kirma N; Liu YG; Flowers L; Evans D; Tekmal RR
    Cancer Res; 2005 Dec; 65(23):11164-73. PubMed ID: 16322267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C; Shan L; Yu M; Snyderwine EG
    Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer.
    Yuan F; Chen DZ; Liu K; Sepkovic DW; Bradlow HL; Auborn K
    Anticancer Res; 1999; 19(3A):1673-80. PubMed ID: 10470100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
    Díaz L; Ceja-Ochoa I; Restrepo-Angulo I; Larrea F; Avila-Chávez E; García-Becerra R; Borja-Cacho E; Barrera D; Ahumada E; Gariglio P; Alvarez-Rios E; Ocadiz-Delgado R; Garcia-Villa E; Hernández-Gallegos E; Camacho-Arroyo I; Morales A; Ordaz-Rosado D; García-Latorre E; Escamilla J; Sánchez-Peña LC; Saqui-Salces M; Gamboa-Dominguez A; Vera E; Uribe-Ramírez M; Murbartián J; Ortiz CS; Rivera-Guevara C; De Vizcaya-Ruiz A; Camacho J
    Cancer Res; 2009 Apr; 69(8):3300-7. PubMed ID: 19351862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
    Mathur RS; Mathur SP
    Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
    Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
    Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells.
    Qiao Y; Cao J; Xie L; Shi X
    Arch Pharm Res; 2009 Sep; 32(9):1309-15. PubMed ID: 19784588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas.
    Kwasniewska A; Postawski K; Gozdzicka-Jozefiak A; Kwasniewski W; Grywalska E; Zdunek M; Korobowicz E
    Oncol Rep; 2011 Jul; 26(1):153-60. PubMed ID: 21491087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on pathogenesis of cervical carcinoma based on the analysis of growth and differentiation mechanism of cervical epithelium].
    Konishi I
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):812-22. PubMed ID: 2172418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas.
    Di GH; Lu JS; Song CG; Li HC; Shen ZZ; Shao ZM
    J Exp Clin Cancer Res; 2005 Dec; 24(4):601-7. PubMed ID: 16471323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
    Kirma N; Gill K; Mandava U; Tekmal RR
    Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.
    Montanaro D; Maggiolini M; Recchia AG; Sirianni R; Aquila S; Barzon L; Fallo F; Andò S; Pezzi V
    J Mol Endocrinol; 2005 Oct; 35(2):245-56. PubMed ID: 16216906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis.
    Elson DA; Riley RR; Lacey A; Thordarson G; Talamantes FJ; Arbeit JM
    Cancer Res; 2000 Mar; 60(5):1267-75. PubMed ID: 10728686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
    Yang XR; Pfeiffer RM; Garcia-Closas M; Rimm DL; Lissowska J; Brinton LA; Peplonska B; Hewitt SM; Cartun RW; Mandich D; Sasano H; Evans DB; Sutter TR; Sherman ME
    Cancer Res; 2007 Nov; 67(21):10608-17. PubMed ID: 17968031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
    Girón RA; Montaño LF; Escobar ML; López-Marure R
    FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
    Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
    Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.